SUBSCRIBE
SUBSCRIBE

Cingulate Therapeutics

NEWS
Drug Development
Clinical Catch-Up: 3’s the Charm for Pfizer-BioNTech Vaccine in Kids & More
A roundup of last week’s top clinical trial announcements and news, including updates from Pfizer, BioNTech, Ocugen and more.
May 27, 2022
 · 
10 min read
 · 
Mark Terry
Bio NC
Anxious? Activate Your Anterior Cingulate Cortex With a Little Meditation, Wake Forest University Baptist Medical Center Study
June 5, 2013
 · 
1 min read
JOBS
IN THE PRESS
BioMidwest
Cingulate Presents Data for Its Triple-Release Buspirone Product Candidate: CTx-2103
September 19, 2022
 · 
7 min read
Business
Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
August 11, 2022
 · 
12 min read
BioMidwest
Kansas City Business Journal Names Cingulate’s Louis G. Van Horn a 2022 Chief Financial Officer of the Year
July 25, 2022
 · 
4 min read
Cingulate Announces Completion of CTx-2103 Human Formulation Study for the Treatment of Anxiety Disorders
June 23, 2022
 · 
7 min read
Cingulate to Present at Diamond Equity Research 2022 Virtual Emerging Growth Invitational
June 17, 2022
 · 
1 min read
BioMidwest
Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event
June 2, 2022
 · 
2 min read
BioMidwest
Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders
May 24, 2022
 · 
9 min read
BioMidwest
Cingulate to Present at H.C. Wainwright Global Investment Conference
May 18, 2022
 · 
1 min read
Business
Cingulate Inc. Reports First Quarter 2022 Results and Provides Clinical and Business Update
May 12, 2022
 · 
9 min read
BioMidwest
Cingulate Presents at NobleCon18
April 26, 2022
 · 
2 min read
Load More